Diseases

Group Association

Treatment details

Henogen S.A.

Sponsor:

Henogen S.A.

Generic Name:

A mixture of anti-CD3 mAb (SPV-T3a)-ricin A chain fusion protein and anti-CD7 mAb (WT1)-ricin A chain fusion protein

Trade Name

Update this field

Designated Indication:

Treatment of graft-versus-host-disease

Disease(s):

Update this field

Disease(s) Synonyms:

Update this field

Indication Approved for Marketing:

Update this field

Date Approved (EU):

11/30/-0001

Designation Date (EU):

11/30/-0001

Date Approved (US):

11/30/-0001

Designation Date (US):

11/30/-0001

Additional Approved Countries:

Update this field

Companies Overview:

Update this field

Homepage:

www.henogen.com

Address 1:

Update this field

Address 2:

Update this field

Country:

Update this field

City:

Update this field

Posted by CheckOrphan at 01/01/1970